solver.press

Post-quantum cryptographic techniques for message transformation can be applied to secure the transmission of sensitive transcriptomic data in Multiple Sclerosis research across distributed networks.

Computer ScienceApr 14, 2026Evaluation Score: 65%

Adversarial Debate Score

68% survival rate under critique

Model Critiques

mistral: The hypothesis is falsifiable and aligns with emerging post-quantum cryptography research, but lacks direct empirical support from the provided papers and faces practical counterarguments (e.g., NISQ-era limitations, computational overhead).
openai: The hypothesis is falsifiable and grounded in plausible application of post-quantum cryptography for securing sensitive data transmission; however, only one cited paper directly addresses post-quantum cryptography in network message transformation, and none explicitly connect these methods to tra...
anthropic: The hypothesis is falsifiable and draws on two directly relevant papers (post-quantum cryptography and MS transcriptomics), making a plausible interdisciplinary connection; however, it conflates distinct domains without mechanistic justification for *why* PQC would be specifically necessary or un...
grok: The hypothesis is falsifiable and partially supported by the paper on post-quantum cryptographic analysis of message transformations, which demonstrates applicability to network security. However, it lacks direct evidence linking these techniques specifically to transcriptomic data in MS research...

Supporting Research Papers

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Post-quantum cryptographic (PQC) algorithms — specifically lattice-based (e.g., CRYSTALS-Kyber/CRYSTALS-Dilithium, NIST PQC Round 3 finalists) and hash-based (e.g., SPHINCS+) schemes — can encrypt, sign, and transmit RNA-seq transcriptomic datasets (≥10,000 gene features, ≥50 patient samples) characteristic of Multiple Sclerosis (MS) research across geographically distributed nodes with: (a) no statistically significant loss of data integrity (bit-error rate = 0), (b) end-to-end latency overhead ≤15% compared to classical AES-256/RSA-2048 baselines, (c) computational overhead ≤3× classical methods on commodity hardware, and (d) resistance to both classical and quantum adversarial attacks as defined by NIST security levels I–V.

Disproof criteria:
  1. INTEGRITY FAILURE: Any non-zero bit-error rate in decrypted transcriptomic data across ≥3 independent transfer trials constitutes disproof of practical applicability.
  2. LATENCY FAILURE: End-to-end transfer latency overhead exceeds 50% over AES-256 baseline for datasets ≥10 GB in ≥5 of 10 trials.
  3. COMPUTATIONAL INFEASIBILITY: Key generation, encapsulation, or decapsulation time exceeds 60 seconds per 1 GB data chunk on reference hardware (Intel Xeon 3.0 GHz, 8 cores), making clinical workflows impractical.
  4. SECURITY BREAK: A published attack reduces effective security of Kyber-768 below 128-bit classical equivalent within the study period.
  5. SCALABILITY COLLAPSE: System throughput degrades super-linearly (>O(n²)) with number of distributed nodes (tested at n = 2, 5, 10, 20, 50).
  6. DATA UTILITY LOSS: Post-decryption differential gene expression (DGE) analysis yields statistically different results (FDR-adjusted p < 0.05, >1% gene set affected) compared to unencrypted baseline, indicating data corruption.
  7. KEY MANAGEMENT FAILURE: Certificate/key exchange failure rate >0.1% across 1,000 simulated connection attempts in adversarial network conditions.

Experimental Protocol

PHASE 1 — Baseline Characterization (Days 1–15): Establish performance benchmarks for classical cryptography (AES-256-GCM + RSA-2048) on MS transcriptomic datasets. Measure throughput, latency, CPU utilization, and memory consumption.

PHASE 2 — PQC Implementation and Unit Testing (Days 16–35): Implement PQC pipeline using liboqs (Open Quantum Safe library) with Kyber-768 for key encapsulation and Dilithium3 for digital signatures. Unit test on synthetic RNA-seq data (simulated via polyester R package).

PHASE 3 — Integration Testing on Real MS Data (Days 36–60): Apply PQC pipeline to publicly available MS transcriptomic datasets (GEO accession GSE138614, n=107 samples; GSE41850, n=140 samples). Measure all performance metrics.

PHASE 4 — Distributed Network Simulation (Days 61–90): Deploy multi-node testbed using Docker/Kubernetes across 3 geographic cloud regions (US-East, EU-West, Asia-Pacific). Simulate adversarial conditions (packet loss 1–5%, latency injection 50–200 ms).

PHASE 5 — Security Audit and Penetration Testing (Days 91–110): Conduct formal security analysis including fuzzing, side-channel timing analysis, and simulated quantum adversary (Grover's algorithm simulation on reduced key sizes).

PHASE 6 — Biological Validity Verification (Days 111–120): Confirm that DGE analysis, pathway enrichment (GSEA), and co-expression network (WGCNA) results are statistically identical pre- and post-encryption/decryption.

Required datasets:
  1. GEO GSE138614: MS peripheral blood mononuclear cell (PBMC) RNA-seq, n=107 (cases/controls), ~15 GB raw FASTQ.
  2. GEO GSE41850: MS brain lesion microarray, n=140 samples, ~2 GB.
  3. GEO GSE131282: MS cerebrospinal fluid transcriptomics, n=60, ~8 GB.
  4. Synthetic RNA-seq: Generated via polyester R package (10,000–50,000 genes, 50–500 samples) for controlled benchmarking — 0 cost.
  5. NIST PQC Reference Implementation: liboqs v0.8.0+ (open source, Apache 2.0).
  6. Network simulation environment: GNS3 or Mininet for WAN emulation.
  7. Reference classical crypto: OpenSSL 3.x with AES-256-GCM and RSA-2048/4096.
  8. Hardware reference platform: AWS c5.4xlarge (16 vCPU, 32 GB RAM) for reproducibility.
  9. MS gene signature databases: MSigDB, ImmPort for biological validation.
  10. Adversarial test suite: NIST Cryptographic Algorithm Validation Program (CAVP) test vectors.
Success:
  1. Data Integrity: SHA-256 checksum match rate = 100% across all 30+ transfer trials (zero bit errors).
  2. Latency Overhead: PQC latency overhead ≤15% vs. AES-256 baseline (mean across all dataset sizes); upper 95% CI ≤25%.
  3. Throughput: PQC-encrypted transfer throughput ≥85% of classical baseline (≥850 MB/s on 10 Gbps link).
  4. Key Operation Speed: Kyber-768 key generation <1 ms, encapsulation <1 ms, decapsulation <1 ms on reference hardware.
  5. Computational Overhead: CPU utilization increase ≤3× classical for equivalent data volume.
  6. Scalability: Linear or sub-linear throughput degradation as nodes increase from 2→50 (R² ≥ 0.85 for linear fit).
  7. Security: Zero timing side-channel vulnerabilities detected; ProVerif formal verification passes; AFL++ fuzzing produces zero critical crashes after 48 hours.
  8. Biological Validity: DGE gene list Jaccard similarity ≥0.99; fold-change Pearson r ≥0.9999; GSEA NES correlation ≥0.999; WGCNA module membership overlap ≥99%.
  9. Availability: System uptime ≥99.5% during 30-day continuous operation test.
  10. Regulatory Alignment: Pipeline demonstrably satisfies HIPAA Technical Safeguard requirements (§164.312).
Failure:
  1. Any non-zero bit error rate in decrypted data across ≥2 independent trials → ABORT.
  2. Latency overhead >50% vs. classical baseline for any dataset size ≥10 GB → FAIL.
  3. Key operation time >10 seconds per operation on reference hardware → FAIL.
  4. CPU overhead >10× classical baseline → FAIL (clinically impractical).
  5. Any critical security vulnerability (CVE-level) discovered during fuzzing or formal analysis → FAIL pending patch.
  6. DGE analysis Jaccard similarity <0.95 between original and decrypted data → FAIL (data corruption).
  7. System crashes or data loss in >1% of transfer attempts under normal network conditions → FAIL.
  8. Throughput <10% of classical baseline → FAIL (operationally unusable).
  9. Memory consumption >256 GB per node (exceeds available hardware) → FAIL without hardware upgrade.
  10. ProVerif formal verification identifies authentication bypass → FAIL.

12

GPU hours

120d

Time to result

$3,200

Min cost

$18,500

Full cost

ROI Projection

Commercial:
  1. Software Licensing: PQC-secured biomedical data transfer platform licensable to pharmaceutical companies, CROs, and hospital networks; estimated TAM $2.3B by 2030 (quantum-safe healthcare IT market).
  2. SaaS Product: Cloud-based PQC transcriptomic data exchange service; estimated ARR $5–15M within 3 years of launch for mid-tier biotech market.
  3. Consulting/Implementation: Protocol implementation services for HIPAA-compliant PQC migration; $500K–$2M per enterprise engagement.
  4. Standards Contribution: Participation in HL7 FHIR quantum-safe extension development; positions organization as standards body contributor.
  5. Partnership Value: Validated pipeline attractive to AWS HealthLake, Google Cloud Healthcare API, Microsoft Azure Health Data Services for integration; potential $10–50M partnership/acquisition value.
  6. Insurance/Compliance Market: Quantum-safe certification for biomedical data pipelines; emerging market estimated at $800M by 2028.
  7. Defense/Government: NIH, DoD, and intelligence community interest in quantum-safe genomic data protection; potential $5–20M in government contracts.

🔓 If proven, this unlocks

Proving this hypothesis is a prerequisite for the following downstream discoveries and applications:

  • 1FEDERATED-LEARNING-MS-PQC-SECURED
  • 2PQC-GENOMIC-DATA-MARKETPLACE
  • 3QUANTUM-SECURE-CLINICAL-TRIAL-NETWORKS
  • 4PQC-MULTIOMICS-INTEGRATION-PIPELINE
  • 5HIPAA-COMPLIANT-PQC-BIOBANK-PROTOCOL
  • 6REAL-TIME-PQC-NEUROIMAGING-TRANSMISSION

Prerequisites

These must be validated before this hypothesis can be confirmed:

  • PQC-NIST-STANDARDIZATION-COMPLETE
  • MS-TRANSCRIPTOMIC-DATA-ACCESS-APPROVAL
  • LIBOQS-STABILITY-VERIFIED
  • DISTRIBUTED-COMPUTE-INFRASTRUCTURE-AVAILABLE
  • IRB-DATA-USE-AGREEMENT-GSE138614

Implementation Sketch

# PQC Transcriptomic Data Transfer Pipeline
# Architecture: Hybrid KEM + Symmetric Encryption + Digital Signature

## SYSTEM ARCHITECTURE
"""
[Data Source Node]          [Transit Layer]         [Recipient Node]
  RNA-seq Data               PQC-TLS 1.3              Decryption
  (FASTQ/BAM/HDF5)    -->   Kyber-768 KEM    -->     Verification
  Chunking (1GB)             AES-256-GCM              DGE Analysis
  Dilithium3 Sign            gRPC/HTTPS               Audit Log
"""

## PSEUDOCODE

# Step 1: Key Setup (run once per session)
def setup_pqc_session(sender_id, receiver_id):
    # Generate Kyber-768 keypair for receiver
    receiver_pk, receiver_sk = kyber768.keygen()
    
    # Generate Dilithium3 keypair for sender (signing)
    sender_sign_pk, sender_sign_sk = dilithium3.keygen()
    
    # Exchange public keys via authenticated channel
    # (bootstrapped with classical PKI, migrated to PQC PKI)
    register_public_key(receiver_id, receiver_pk)
    register_public_key(sender_id, sender_sign_pk)
    
    return sender_sign_sk, receiver_pk

# Step 2: Data Preparation
def prepare_transcriptomic_data(filepath, chunk_size_gb=1):
    data = load_genomic_file(filepath)  # FASTQ/BAM/HDF5
    chunks = split_into_chunks(data, chunk_size_gb * 1024**3)
    checksums = [sha256(chunk) for chunk in chunks]
    manifest = create_manifest(filepath, checksums, timestamp=now())
    return chunks, manifest

# Step 3: Encryption (per chunk)
def encrypt_chunk_pqc(chunk, receiver_pk, sender_sign_sk):
    # KEM: encapsulate shared secret
    ciphertext_kem, shared_secret = kyber768.encapsulate(receiver_pk)
    
    # Derive AES key from shared secret
    aes_key = hkdf_sha256(shared_secret, salt=os.urandom(32), 
                           info=b"MS-transcriptomics-v1", length=32)
    
    # Encrypt chunk with AES-256-GCM
    nonce = os.urandom(12)
    ciphertext_data, tag = aes_256_gcm_encrypt(aes_key, nonce, chunk)
    
    # Sign the encrypted chunk
    payload = ciphertext_kem + nonce + ciphertext_data + tag
    signature = dilithium3.sign(payload, sender_sign_sk)
    
    # Package
    encrypted_chunk = {
        'kem_ciphertext': ciphertext_kem,    # 1088 bytes (Kyber-768)
        'nonce': nonce,                       # 12 bytes
        'data_ciphertext': ciphertext_data,   # variable
        'aes_tag': tag,                       # 16 bytes
        'signature': signature,               # 3293 bytes (Dilithium3)
        'chunk_id': uuid4(),
        'algorithm': 'KYBER768-AES256GCM-DILITHIUM3'
    }
    return encrypted_chunk

# Step 4: Transmission
def transmit_encrypted_dataset(encrypted_chunks, manifest, 
                                 receiver_endpoint):
    session = establish_pqc_tls_session(receiver_endpoint)
    
    # Send manifest first
    send_with_retry(session, serialize(manifest), max_retries=3)
    
    # Stream chunks with flow control
    for i, chunk in enumerate(encrypted_chunks):
        ack = send_with_retry(session, serialize(chunk), max_retries=5)
        if not ack.success:
            raise TransmissionError(f"Chunk {i} failed after 5 retries")
        log_transfer_metric(chunk_id=chunk['chunk_id'], 
                           bytes_sent=len(chunk['data_ciphertext']),
                           latency_ms=ack.latency)
    
    return TransferReceipt(manifest_hash=sha256(manifest), 
                           total_chunks=len(encrypted_chunks))

# Step 5: Decryption and Verification
def decrypt_and_verify(encrypted_chunks, receiver_sk, 
                        sender_sign_pk, expected_manifest):
    decrypted_chunks = []
    
    for chunk in encrypted_chunks:
        # Verify signature first
        payload = (chunk['kem_ciphertext'] + chunk['nonce'] + 
                   chunk['data_ciphertext'] + chunk['aes_tag'])
        if not dilithium3.verify(payload, chunk['signature'], sender_sign_pk):
            raise SecurityError(f"Signature verification FAILED chunk {chunk['chunk_id']}")
        
        # Decapsulate shared secret
        shared_secret = kyber768.decapsulate(chunk['kem_ciphertext'], receiver_sk)
        
        # Derive AES key
        aes_key = hkdf_sha256(shared_secret, salt=..., 
                               info=b"MS-transcriptomics-v1", length=32)
        
        # Decrypt
        plaintext = aes_256_gcm_decrypt(aes_key, chunk['nonce'], 
                                         chunk['data_ciphertext'], chunk['aes_tag'])
        decrypted_chunks.append(plaintext)
    
    # Reassemble and verify integrity
    full_data = reassemble_chunks(decrypted_chunks)
    verify_manifest_checksums(full_data, expected_manifest)
    
    return full_data

# Step 6: Biological Validation
def validate_biological_integrity(original_path, decrypted_data):
    original = load_count_matrix(original_path)
    decrypted = load_count_matrix(decrypted_data)
    
    # Bit-level check
    assert sha256(original) == sha256(decrypted), "INTEGRITY FAILURE"
    
    # Biological-level check (DESeq2 via rpy2)
    dge_original = run_deseq2(original, design="~condition")
    dge_decrypted = run_deseq2(decrypted, design="~condition")
    
    jaccard = compute_jaccard(dge_original.sig_genes, dge_decrypted.sig_genes)
    pearson_r = correlate(dge_original.log2fc, dge_decrypted.log2fc)
    
    assert jaccard >= 0.99, f"Biological validity FAILED: Jaccard={jaccard}"
    assert pearson_r >= 0.9999, f"Fold-change correlation FAILED: r={pearson_r}"
    
    return ValidationReport(jaccard=jaccard, pearson_r=pearson_r, 
                            integrity="PASS")

## BENCHMARKING HARNESS
def run_benchmark_suite(dataset_sizes_gb=[1, 10, 50, 100], 
                         n_trials=10, crypto_modes=['classical', 'pqc']):
    results = []
    for size in dataset_sizes_gb:
        data = generate_synthetic_rnaseq(size_gb=size)
        for mode in crypto_modes:
            for trial in range(n_trials):
                t_start = time.perf_counter()
                if mode == 'pqc':
                    encrypted = encrypt_chunk_pqc(data, receiver_pk, sign_sk)
                    transmitted = transmit_encrypted_dataset([encrypted], ...)
                    decrypted = decrypt_and_verify([encrypted], ...)
                else:
                    encrypted = aes256_encrypt(data)
                    transmitted = transmit_classical(encrypted)
                    decrypted = aes256_decrypt(encrypted)
                t_end = time.perf_counter()
                
                results.append({
                    'size_gb': size, 'mode': mode, 'trial': trial,
                    'latency_s': t_end - t_start,
                    'throughput_mbps': (size*1024) / (t_end - t_start),
                    'cpu_pct': psutil.cpu_percent(),
                    'mem_gb': psutil.virtual_memory().used / 1e9
                })
    
    return pd.DataFrame(results)

## DEPLOYMENT CONFIGURATION (docker-compose excerpt)
"""
services:
  pqc-sender:
    image: pqc-transcriptomics:v1.0
    environment:
      - KYBER_SECURITY_LEVEL=768
      - DILITHIUM_LEVEL=3
      - CHUNK_SIZE_GB=1
      - MAX_RETRIES=5
    volumes:
      - /data/rnaseq:/data:ro
      
  pqc-receiver:
    image: pqc-transcriptomics:v1.0
    ports:
      - "8443:8443"  # PQC-TLS
    environment:
      - VERIFY_SIGNATURES=true
      - AUDIT_LOG=true
"""
Abort checkpoints:

CHECKPOINT 1 — Day 7 (Data Acquisition Complete): ABORT IF: GEO datasets unavailable or data use agreement denied for >2 of 3 primary datasets. Action: Switch to fully synthetic data only; note limitation in scope.

CHECKPOINT 2 — Day 15 (Baseline Benchmarking Complete): ABORT IF: Classical AES-256 baseline throughput <50 MB/s on reference hardware (indicates infrastructure problem, not cryptographic). Action: Diagnose and fix infrastructure before proceeding.

CHECKPOINT 3 — Day 30 (PQC Unit Testing Complete): ABORT IF: liboqs CAVP test vector validation fails for Kyber-768 or Dilithium3. Action: Downgrade to previous stable liboqs version; file bug report; do not proceed with broken implementation.

CHECKPOINT 4 — Day 40 (Integration Testing — First Data Integrity Check): ABORT IF: Any bit error detected in decrypted output on first 5 integration tests. Action: Full debug of encryption/decryption pipeline before any further testing; this is a hard stop.

CHECKPOINT 5 — Day 55 (Distributed Deployment — 2-Node Test): ABORT IF: 2-node transfer failure rate >5% under normal network conditions. Action: Debug network/protocol layer; do not scale to more nodes until 2-node is stable.

CHECKPOINT 6 — Day 65 (Performance Benchmarking — Preliminary Results): ABORT IF: PQC latency overhead >200% vs. classical baseline for 10 GB dataset. Action: Profile bottlenecks; if fundamental algorithmic limitation (not implementation bug), revise hypothesis scope to smaller datasets only.

CHECKPOINT 7 — Day 80 (Security Analysis — Fuzzing Midpoint): ABORT IF: AFL++ discovers memory corruption vulnerability (heap overflow, use-after-free) in PQC API. Action: Halt all testing; patch vulnerability; restart security phase from Day 76.

CHECKPOINT 8 — Day 90 (Security Analysis Complete): ABORT IF: ProVerif identifies authentication bypass or key compromise in protocol model. Action: Redesign key exchange protocol; this constitutes a fundamental security failure requiring protocol revision before biological validation.

CHECKPOINT 9 — Day 100 (Biological Validity — Preliminary): ABORT IF: DGE Jaccard similarity <0.90 on first biological validation run. Action: Investigate data corruption pathway; if systematic, abort and report as negative result with full methodology.

CHECKPOINT 10 — Day 110 (Full Results Available): GO/NO-GO DECISION: If ≥7 of 10 success criteria are met → proceed to publication. If 4

📡 New evidence since EVP generation

Discoveries published after this EVP was written that relate to its hypothesis or downstream unlocks.

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started